Rare diseases
Investigational molecules
Locations
20 Acorn Park Drive Suite 500, 02140-2133, United States
Arbor Biotechnologies Inc. focuses on clinical research in Primary Hyperoxaluria Type 1, a rare inherited metabolic disorder associated with abnormal oxalate production and kidney complications.
The sponsor’s research interest is centered on conditions affecting renal metabolism and the clinical burden of progressive kidney damage in rare disease.
Arbor Biotechnologies Inc. runs clinical trials in conditions such as Primary hyperoxaluria, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
